Overview
Lobbying Costs
650,000€
Financial year: Jan 2012 - Dec 2012
Lobbyists (Full time equivalent)
None declared
Lobbyists with EP accreditation
3
High-level Commission meetings
30
Lobbying Costs over the years
-
Info
Novartis International AG
EU Transparency Register
91269481588-28 First registered on 27 Apr 2009
Goals / Remit
Our mission is to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. Our complementary healthcare businesses address the changing needs of patients and societies worldwide. With innovative pharmaceuticals at the core, we are also a global leader in generics, eyecare, vaccines and consumer health products.
In 2008, Novartis invested USD 7.2 billion in R&D activities. This is one of the highest figures in the industry relative to net sales (17.4%).
With approximately 130 000 associates in 140 countries worldwide, Novartis associates share a vision of a better today and tomorrow for patients.
Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment.
During 2008, medicines and vaccines from Novartis treated and protected more than (estimated) 850 million people around the world. Novartis contributed treatments worth USD 1.26 billion through access-to-medicine programs, reaching 74 million patients in need.Main EU files targeted
Address
Head Office
Novartis International AG
Basel CH-4002
SWITZERLAND -
People
Total lobbyists declared
None declared
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
3 accreditations were / are live (in bold) for the selected state of 15 Apr 2013
Name Start date End Date Christian Thonke 27 Oct 2023 25 Oct 2024 Wojciech Nowak 27 Oct 2023 25 Oct 2024 Aoiffe O'BRIEN 05 Jul 2023 04 Jul 2024 Sarah MOUNDIR 30 Nov 2023 28 Nov 2024 Julie Chauvet 24 Nov 2023 22 Nov 2024 Ms Sarah MOUNDIR 30 Nov 2023 15 Apr 2024 Ms Julie Chauvet 24 Nov 2023 15 Apr 2024 Mr Christian Thonke 27 Oct 2023 15 Apr 2024 Mr Wojciech Nowak 27 Oct 2023 15 Apr 2024 Ms Véronique MASI 07 Jul 2023 18 Jan 2024 Ms Aoiffe O'BRIEN 05 Jul 2023 15 Apr 2024 Mr Vincent VANWIJNSBERGHE 05 Jul 2023 03 Oct 2023 Ms Julie Chauvet 09 Nov 2022 09 Nov 2023 Mr Arnaud MAHEAS 09 Sep 2022 30 Jun 2023 Ms Elke Grooten 09 Aug 2022 30 Jun 2023 Ms Sarah MOUNDIR 05 Aug 2022 05 Aug 2023 Ms Julie Chauvet 19 Oct 2021 19 Oct 2022 Ms Laura KOENE 23 Sep 2021 23 Sep 2022 Ms Sarah MOUNDIR 04 Aug 2021 04 Aug 2022 Ms Elke Grooten 15 Jul 2021 15 Jul 2022 Ms Sarah MOUNDIR 03 Oct 2020 04 Aug 2021 Ms Julie Chauvet 20 Feb 2020 01 Mar 2021 Ms Ivana CATTANEO 20 Feb 2020 20 Feb 2021 Mr Wojciech Nowak 20 Feb 2020 20 Feb 2021 Ms Maria CARUSO 20 Feb 2020 01 Sep 2020 Ms Elke Grooten 08 Jan 2020 08 Jan 2021 Ms Tiziana DE FEO 23 Nov 2019 21 Nov 2020 Mr Arnaud MAHEAS 07 Nov 2019 07 Nov 2020 Ms Maria CARUSO 06 Sep 2019 20 Feb 2020 Ms Ivana CATTANEO 08 Mar 2019 20 Feb 2020 Mr Joerg Jenewein 20 Feb 2019 20 Feb 2020 Ms Julie Chauvet 12 Feb 2019 12 Feb 2020 Mr Maximilian Alexander GÖTZ VON OLENHUSEN 29 Jan 2019 06 Sep 2019 Mr Wojciech Nowak 29 Jan 2019 01 Feb 2020 Ms Francesca Maria RISSO 24 Jan 2019 24 Jul 2019 Ms Gemma DIEZ LORENTE 18 Sep 2018 24 Jan 2019 Ms ludovica moccaldi 13 Sep 2018 08 May 2019 Ms Ivana CATTANEO 14 Mar 2018 08 Mar 2019 Ms Gemma DIEZ LORENTE 14 Mar 2018 18 Sep 2018 Ms Julie Chauvet 24 Feb 2018 12 Feb 2019 Mr Maximilian Alexander GÖTZ VON OLENHUSEN 20 Jan 2018 19 Jan 2019 Mr Joerg Jenewein 13 Dec 2017 13 Dec 2018 Mr Florian Erny 27 Oct 2017 02 Jun 2018 Ms Ivana CATTANEO 20 Sep 2017 14 Mar 2018 Ms Elisa Balducci 08 Sep 2017 10 Jan 2018 Mr Wojciech Nowak 31 Aug 2017 22 Aug 2018 Ms Danielle Powell 20 Jul 2017 01 Aug 2017 Ms ludovica moccaldi 20 May 2017 19 May 2018 Ms Elisa Balducci 20 Mar 2017 07 Sep 2017 Ms Julie Chauvet 28 Feb 2017 24 Feb 2018 Mr Maximilian Alexander GÖTZ VON OLENHUSEN 23 Jan 2017 17 Jan 2018 Mr Joerg Jenewein 01 Dec 2016 01 Dec 2017 Mr Florian Erny 10 Nov 2016 27 Oct 2017 Mr Wojciech Nowak 22 Aug 2016 30 Jul 2017 Ms Nina Brkuljan 30 Jun 2016 29 Dec 2016 Ms Marie Blanchard 23 Jun 2016 24 Jan 2017 Mr Maximilian Alexander GÖTZ VON OLENHUSEN 08 Jan 2016 07 Jan 2017 Mr Sture Alne 08 Jan 2016 07 Jul 2016 Mr Joerg Jenewein 04 Dec 2015 01 Dec 2016 Mr Florian Erny 18 Nov 2015 10 Nov 2016 Ms Elke Grooten 16 Sep 2015 14 Sep 2016 Ms Marie Blanchard 30 Jun 2015 23 Jun 2016 Ms Claudia Gherman 06 May 2015 06 Jan 2016 Ms Mathilde Panhaleux 12 Mar 2015 25 Apr 2015 Mr Joaquin de Santos 10 Mar 2015 05 Sep 2015 Ms Elke Grooten 06 Sep 2014 04 Sep 2015 Mr Maximilian Alexander GÖTZ VON OLENHUSEN 13 Jan 2015 08 Jan 2016 Mr Joerg Jenewein 18 Dec 2014 04 Dec 2015 Ms Lea Pfefferle 11 Sep 2014 03 Mar 2015 Mrs Elke Grooten 06 Sep 2014 27 Jan 2015 Ms Emily Darrow 07 Aug 2014 12 Feb 2015 Mr Brendan Moran 25 Jul 2014 29 Jan 2015 Ms Marie Blanchard 04 Jul 2014 30 Jun 2015 Mr Joaquin de Santos 11 Mar 2014 08 Mar 2015 Ms Lea Pfefferle 08 Mar 2014 07 Sep 2014 Mr Maximilian Alexander GÖTZ VON OLENHUSEN 23 Jan 2014 13 Jan 2015 Mr Joerg Jenewein 07 Dec 2013 06 Dec 2014 Ms Lea Pfefferle 06 Sep 2013 05 Mar 2014 Ms Elisaveta Voynova 26 Jun 2013 12 Sep 2013 Mr Joaquin de Santos 12 Apr 2013 11 Mar 2014 Ms Elisaveta Voynova 26 Feb 2013 22 Jun 2013 Mr Joaquin de Santos 26 Jan 2013 12 Apr 2013 Mr Maximilian Alexander GÖTZ VON OLENHUSEN 06 Feb 2013 23 Jan 2014 Mr Maximilian Alexander GÖTZ VON OLENHUSEN 07 Feb 2012 08 Feb 2013 Complementary Information
None declared
Person in charge of EU relations
None declared
Person with legal responsibility
Mr Andras Fehervary (Head of Government & Public Affairs Europe)
-
Categories
Category
II - In-house lobbyists and trade/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2012 - Dec 2012
Lobbying costs for closed financial year
650,000€
Other financial info
The estimated costs are calculated based on the proportion of working time spent by Novartis associates on representing interests to the EU institutions in 2012. This proportion is applied to the overall personnel and overhead costs.
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
None declared
Communication activities
None declared
Other activities
None declared
- Meetings
Meetings
30 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 06 Mar 2023 Location Brussels Subject Pharma package Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Kevin Keary (Cabinet member)
Other Lobbyists -
Date 13 Feb 2023 Location Brussels Subject EU strategic autonomy in the health sector Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
-
Date 10 Jan 2023 Location Brussels Subject Commission Proposal for Directive on sustainability - Due Diligence (CSDDD) Cabinet Cabinet of Commissioner Didier Reynders Portfolio Justice Attending - Lucrezia Busa (Cabinet member)
- Ludovic Pierre (Cabinet member)
-
Date 06 Oct 2022 Location Videoconference Subject Energy prices’ impact on generic medicines manufacturing Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
- Eszter Batta (Cabinet member)
-
Date 18 Feb 2021 Location Videoconference Subject COVID-19 vaccines production Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
- Thierry Breton (Commissioner)
-
Date 03 Sep 2020 Location Videoconference Subject Keeping existing pharmaceutical manufacturing capacity in the EU Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
-
Date 07 Apr 2020 Location Brussels Subject Discussion on medicines (Production, clinical tests, supply and allocation) Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 05 Feb 2020 Location Brussels Subject Discussion on Cancer and Europe's Beating Cancer Plan Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Tove Ernst (Cabinet member)
- Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 27 Nov 2018 Location Brussels Subject Access to health services, including pharmaceuticals, in developing countries Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 27 Nov 2018 Location Brussels Subject Health research in Horizon Europe Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Giulia Del Brenna (Cabinet member)
-
Date 21 Feb 2018 Location Brussels Subject HTA; Supplementary Protection Certificates (SPC) Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
Other Lobbyists -
Date 15 Feb 2018 Location Brussels Subject pharmaceutical IP incentives Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Fabrice Comptour (Cabinet member)
- Kaius Kristian Hedberg (Cabinet member)
Other Lobbyists -
Date 01 Feb 2018 Location Brussels Subject Patent Issues Cabinet Cabinet of Vice-President Miguel Arias Cañete Portfolio Climate Action & Energy Attending - Pierre Schellekens (Cabinet member)
-
Date 25 Jan 2018 Location Brussels Subject European patent protection Cabinet Cabinet of Commissioner Pierre Moscovici Portfolio Economic and Financial Affairs, Taxation and Customs Attending - Lucie Mattera (Cabinet member)
Other Lobbyists -
Date 25 Jan 2018 Location Brussels Subject Business discussion Cabinet Cabinet of Commissioner Phil Hogan Portfolio Agriculture & Rural Development Attending - Tom Tynan (Cabinet member)
-
Date 25 Jan 2018 Location Davos Subject health policy Cabinet Cabinet of Vice-President Günther Oettinger Portfolio Budget & Human Resources Attending - Günther Oettinger (Commissioner)
-
Date 21 Nov 2017 Location Brussels Subject Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC) and patent research exemptions; innovation in the pharmaceutical industry Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Jyrki Katainen (Vice-President)
Other Lobbyists -
Date 21 Nov 2017 Location Brussels Subject research budget Cabinet Cabinet of Vice-President Günther Oettinger Portfolio Budget & Human Resources Attending - Günther Oettinger (Commissioner)
-
Date 08 Nov 2017 Location Brussels Subject Economy and Investment in the EU Neighbourhood Cabinet Cabinet of Vice-President Johannes Hahn Portfolio European Neighbourhood Policy & Enlargement Negotiations Attending - Michael Karnitschnig (Cabinet member)
-
Date 08 Nov 2017 Location Brussels Subject E Health Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Manuel Mateo-Goyet (Cabinet member)
-
Date 07 Nov 2017 Location Brussels Subject Innovation and patents in trade policy Cabinet Cabinet of Vice-President Cecilia Malmström Portfolio Trade Attending - Miguel Ceballos Baron (Cabinet member)
-
Date 18 Jan 2017 Location Davos Subject Data, e-health Cabinet Cabinet of Vice-President Andrus Ansip Portfolio Digital Single Market Attending - Aare Järvan (Cabinet member)
- Andrus Ansip (Vice-President)
-
Date 03 Jun 2015 Location Brussels Subject New College and Better Regulation DG Communications Networks, Content and Technology Attending - Robert Madelin (Director-General)
Other Lobbyists - Oracle
- Dow Europe GmbH
- Syngenta Crop Protection AG
- GIGAEurope aisbl
- Toy Industries of Europe
- European Centre for Public Affairs
- The Walt Disney Company Benelux BVBA
- Acumen Public Affairs
- European Academy of Dermatology and Venereology
- Cargill
- Jaguar Land Rover Limited
- European Chemical Industry Council
- Association des Constructeurs Européens d'Automobiles
- spiritsEUROPE
- RTL Group
- MERIAL
- SANOFI
- American Chamber of Commerce to the European Union
- CEMBUREAU - The European Cement Association
- RELX
- CEMA - European Agricultural Machinery Industry Association
- FoodDrinkEurope
-
Date 03 Jun 2015 Location Brussels Subject New College and Better Regulation DG Communications Networks, Content and Technology Attending - Robert Madelin (Director-General)
Other Lobbyists - Dow Europe GmbH
- Jaguar Land Rover Limited
- Syngenta Crop Protection AG
- Association des Constructeurs Européens d'Automobiles
- European Centre for Public Affairs
- spiritsEUROPE
- The Walt Disney Company Benelux BVBA
- MERIAL
- Acumen Public Affairs
- RELX
- CEMA - European Agricultural Machinery Industry Association
- FoodDrinkEurope
- European Chemical Industry Council
- Oracle
- RTL Group
- GIGAEurope aisbl
- SANOFI
- Toy Industries of Europe
- American Chamber of Commerce to the European Union
- CEMBUREAU - The European Cement Association
- European Academy of Dermatology and Venereology
- Cargill
-
Date 13 Mar 2015 Location Brussels Subject Industrial Policy for pharmaceuticals DG Internal Market, Industry, Entrepreneurship and SMEs Attending - Daniel Calleja Crespo (Director-General)
-
Date 12 Feb 2015 Location Brussels Subject Digital Single Market, Innovation DG Communications Networks, Content and Technology Attending - Robert Madelin (Director-General)
Other Lobbyists -
Date 12 Feb 2015 Location Brussels Subject Digital Single Market, Innovation DG Communications Networks, Content and Technology Attending - Robert Madelin (Director-General)
Other Lobbyists -
Date 23 Jan 2015 Location Davos Subject Bilateral meeting the CEO of Novartis & EFPIA President Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Carlos Moedas (Commissioner)
-
Date 16 Jan 2015 Location PRAGUE, CZECH REPUBLIC Subject Round Table on Gender Diversity Cabinet Cabinet of Commissioner Věra Jourová Portfolio Justice, Consumers and Gender Equality Attending - Věra Jourová (Commissioner)
Other Lobbyists
- Meetings